Alexander Helfand, MD
Alt: (412) 325-5700
Fax: (412) 442-2570
Business hours
| Monday | 8:00am to 4:00pm |
| Tuesday | 8:00am to 4:00pm |
| Wednesday | 8:00am to 4:00pm |
| Thursday | 8:00am to 4:00pm |
| Friday | 8:00am to 4:00pm |
| Saturday | - |
| Sunday | - |
About us
Alexander Helfand, MD, is a medical oncologist and hematologist with AHN Cancer Institute, specializing in providing compassionate and empathetic oncologic and hematologic care. He diagnoses and treats blood-related illness and cancer. Dr. Helfand went to medical school at Sackler School of Medicine, New York State/American Program, in Tel Aviv, Israel. Upon completion of medical school, he did his residency at Weill Cornell Medicine: New York Presbyterian – Brooklyn Methodist Hospital in Brooklyn, New York and his fellowship in hematology/oncology at Allegheny General Hospital in Pittsburgh, Pennsylvania. Dr. Helfand is certified by the American Board of Internal Medicine and is affiliated with the American Society of Hematology and the American Society of Clinical Oncology. He speaks Spanish and Hebrew and sees patients ages 18 and older.
Call today!
| Languages | English |
| Services | transitional cell carcinoma, cancer clinical trials, active surveillance for kidney cancer, kidney cancer clinical trials, bladder cancer immunotherapy, malignant neoplasm of ureter, prostate cancer clinical trials, bladder cancer clinical trials, non-clear cell kidney cancer, testicular cancer, urethral cancer, human papillomavirus (hpv) related penile cancer, penile cancer chemotherapy, penile cancer, clear cell renal cancer, testicular tumor, hereditary kidney cancer, testicular cancer chemotherapy, genitourinary cancers, prostate cancer, bladder cancer, scrotal tumor, kidney cancer, adjuvant chemotherapy, chemotherapy iv infusion, multi-cancer early detection blood test, advanced malignancies, systemic therapy, intravesical chemotherapy, personal history of chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), prostate cancer chemotherapy, bladder cancer chemotherapy, hormone based chemotherapy, intravesical therapy, carcinoma of unknown primary, targeted molecular therapy, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, urachal tumor, clinical trials, intraarterial chemotherapy of tumors, cancer immunotherapy, abdominal chemotherapy, abdominal cancer, intraperitoneal hyperthermic chemoperfusion, cancer pain, cancer genomics, cancer during pregnancy, biological targeted therapy, cancer chemotherapy, cancer |